Curis
CRIS
#11016
Rank
A$4.84 M
Marketcap
A$2.00
Share price
-4.03%
Change (1 day)
-20.34%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): A-$34.90

According to Curis's latest financial reports the company's current EPS (TTM) is A-$33.23. In 2025 the company made an earnings per share (EPS) of A-$33.23 an increase over its 2024 EPS that were of A-$196.29.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$34.905.02%
2025A-$33.23-83.07%
2024A-$196.29-22.15%
2023A-$252.14-26.17%
2022A-$341.4922.3%
2021A-$279.22-25.37%
2020A-$374.15-30.93%
2019A-$541.69-2.02%
2018A-$552.86
2016A-$1,256-10%
2015A-$1,396138.1%
2014A-$586.3640%
2013A-$418.83-25%
2012A-$558.4466.67%
2011A-$335.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.83-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.97-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.50-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.37-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.95-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$7.04-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$0.24-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA